Dr. Peter Schultz is a founder and scientific advisor to Wildcat. In addition, Dr. Schultz is currently a Professor of Chemistry at The Scripps Research Institute and is the former Institute Director for the Genomics Institute of the Novartis Research Foundation. Dr. Schultz has pioneered combinatorial approaches to the physical and life sciences.
He was the founder of Symyx Technologies, which has had a large commercial impact in the materials and catalysis fields, including partnerships with Exxon-Mobil, Dow and others. He is a member of the National Academy of Sciences and the Institute of Medicine of the National Academy of Sciences. Dr. Schultz is a founding scientist of Affymax Research Institute and co-founder of Symyx, Syrrx, Kalypsys, Phenomix, Ilypsa, and Ambrx.